<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JOP</journal-id>
<journal-id journal-id-type="hwp">spjop</journal-id>
<journal-id journal-id-type="nlm-ta">J Psychopharmacol</journal-id>
<journal-title>Journal of Psychopharmacology</journal-title>
<issn pub-type="ppub">0269-8811</issn>
<issn pub-type="epub">1461-7285</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269881112446531</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269881112446531</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of methylphenidate on basic and higher-order oculomotor functions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Allman</surname><given-names>Ava-Ann</given-names></name>
<xref ref-type="aff" rid="aff1-0269881112446531">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ettinger</surname><given-names>Ulrich</given-names></name>
<xref ref-type="aff" rid="aff1-0269881112446531">1</xref>
<xref ref-type="aff" rid="aff2-0269881112446531">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Joober</surname><given-names>Ridha</given-names></name>
<xref ref-type="aff" rid="aff3-0269881112446531">3</xref>
<xref ref-type="aff" rid="aff4-0269881112446531">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>O’Driscoll</surname><given-names>Gillian A</given-names></name>
<xref ref-type="aff" rid="aff1-0269881112446531">1</xref>
<xref ref-type="aff" rid="aff3-0269881112446531">3</xref>
<xref ref-type="aff" rid="aff4-0269881112446531">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0269881112446531"><label>1</label>Department of Psychology, McGill University, Montreal, QC, Canada</aff>
<aff id="aff2-0269881112446531"><label>2</label>Faculty of Psychology, University of Munich, Munich, Germany</aff>
<aff id="aff3-0269881112446531"><label>3</label>Department of Psychiatry, McGill University, Montreal, QC, Canada</aff>
<aff id="aff4-0269881112446531"><label>4</label>Douglas Mental Health University Institute, Montreal, QC, Canada</aff>
<author-notes>
<corresp id="corresp1-0269881112446531">Gillian O’Driscoll, Department of Psychology, McGill University, 1205 Dr Penfield Ave., Montreal, QC, H3Z 2G3, Canada Email: <email>gillian@hebb.psych.mcgill.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>11</issue>
<fpage>1471</fpage>
<lpage>1479</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">British Association for Psychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Eye movements are sensitive indicators of pharmacological effects on sensorimotor and cognitive processing. Methylphenidate (MPH) is one of the most prescribed medications in psychiatry. It is increasingly used as a cognitive enhancer by healthy individuals. However, little is known of its effect on healthy cognition. Here we used oculomotor tests to evaluate the effects of MPH on basic oculomotor and executive functions. Twenty-nine males were given 20mg of MPH orally in a double-blind placebo-controlled crossover design. Participants performed visually-guided saccades, sinusoidal smooth pursuit, predictive saccades and antisaccades one hour post-capsule administration. Heart rate and blood pressure were assessed prior to capsule administration, and again before and after task performance. Visually-guided saccade latency decreased with MPH (<italic>p</italic>&lt;0.004). Smooth pursuit gain increased on MPH (<italic>p</italic>&lt;0.001) and number of saccades during pursuit decreased (<italic>p</italic>&lt;0.001). Proportion of predictive saccades increased on MPH (<italic>p</italic>&lt;0.004), specifically in conditions with predictable timing. Peak velocity of predictive saccades increased with MPH (<italic>p</italic>&lt;0.01). Antisaccade errors and latency were unaffected. Physiological variables were also unaffected. The effects on visually-guided saccade latency and peak velocity are consistent with MPH effects on dopamine in basal ganglia. The improvements in predictive saccade conditions and smooth pursuit suggest effects on timing functions.</p>
</abstract>
<kwd-group>
<kwd>Saccades</kwd>
<kwd>smooth pursuit</kwd>
<kwd>methylphenidate</kwd>
<kwd>dopamine</kwd>
<kwd>motor planning</kwd>
<kwd>inhibition</kwd>
<kwd>cognitive enhancers</kwd>
<kwd>executive function</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0269881112446531" sec-type="intro">
<title>Introduction</title>
<p>Methylphenidate (MPH) is a psychostimulant whose major actions include increasing the availability of dopamine (DA) and noradrenaline (NA) by blocking the DA transporter (<xref ref-type="bibr" rid="bibr29-0269881112446531">Heal et al., 2009</xref>). MPH is the primary treatment for Attention Deficit Hyperactivity Disorder (ADHD) (<xref ref-type="bibr" rid="bibr20-0269881112446531">Dodson, 2005</xref>), where its cognitive-enhancing properties have been documented (<xref ref-type="bibr" rid="bibr50-0269881112446531">Kurscheidt et al., 2008</xref>; <xref ref-type="bibr" rid="bibr69-0269881112446531">Pietrzak et al., 2006</xref> but see <xref ref-type="bibr" rid="bibr10-0269881112446531">Bidwell et al., 2011</xref>; <xref ref-type="bibr" rid="bibr83-0269881112446531">Swanson et al., 2011</xref>).</p>
<p>Recently, there has been an increase in the off-label use of MPH as a cognitive enhancer in healthy individuals (<xref ref-type="bibr" rid="bibr1-0269881112446531">Advokat et al., 2008</xref>; <xref ref-type="bibr" rid="bibr96-0269881112446531">Wilens et al., 2008</xref>), but empirical support for cognitive enhancing effects in this population is relatively sparse. A recent review of the small available literature showed reliable effects in healthy individuals only on memory (<xref ref-type="bibr" rid="bibr71-0269881112446531">Repantis et al., 2010</xref>).</p>
<p>Eye movement tasks are well suited to examine drug effects (<xref ref-type="bibr" rid="bibr70-0269881112446531">Reilly et al., 2008</xref>). Their neurophysiological and neurochemical bases have been well established in non-human primates (<xref ref-type="bibr" rid="bibr34-0269881112446531">Ilg and Thier, 2008</xref>; <xref ref-type="bibr" rid="bibr41-0269881112446531">Johnston and Everling, 2008</xref>; <xref ref-type="bibr" rid="bibr48-0269881112446531">Kori et al., 1995</xref>), and neuroimaging studies have identified homologous regions in the human brain that subserve these tasks (<xref ref-type="bibr" rid="bibr52-0269881112446531">Lencer and Trillenberg, 2008</xref>; <xref ref-type="bibr" rid="bibr53-0269881112446531">McDowell et al., 2008</xref>). Matched control conditions allow higher order functions of interest to be isolated. Task demands are simple, minimizing effects on education level or IQ. Finally, performance on oculomotor tasks can be reliably measured across time (<xref ref-type="bibr" rid="bibr25-0269881112446531">Ettinger et al., 2003</xref>), and are thus suitable for comparisons between drug and placebo.</p>
<p>To date, MPH effects on eye movements have been studied only in ADHD. Below we briefly review this literature focusing on visually-guided saccades, smooth pursuit, predictive saccades and antisaccades.</p>
<p>In the visually-guided saccade task the participant shifts gaze to keep an unpredictably and abruptly moving target on the fovea. Most studies find MPH to reduce saccade reaction times in ADHD (<xref ref-type="bibr" rid="bibr46-0269881112446531">Klein et al., 2002</xref>; <xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>; but see <xref ref-type="bibr" rid="bibr59-0269881112446531">Mostofsky et al., 2001</xref>) without affecting other variables.</p>
<p>Smooth pursuit is used to keep a slowly moving target on the fovea. Children with ADHD are not significantly impaired in pursuit (<xref ref-type="bibr" rid="bibr15-0269881112446531">Castellanos et al., 2005</xref>; <xref ref-type="bibr" rid="bibr38-0269881112446531">Jacobsen et al., 1996</xref>) but in the two available studies, MPH improved pursuit in this population (<xref ref-type="bibr" rid="bibr6-0269881112446531">Bala et al., 1981</xref>; <xref ref-type="bibr" rid="bibr12-0269881112446531">Bylsma and Pivik, 1989</xref>).</p>
<p>The predictive saccade task involves tracking a target that steps predictably and rhythmically in time and space. This task is thought to tap into motor planning and temporal processing (<xref ref-type="bibr" rid="bibr42-0269881112446531">Joiner and Shelhamer, 2006</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>). Predictive saccade performance is impaired in ADHD (<xref ref-type="bibr" rid="bibr27-0269881112446531">Feifel et al., 2004</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>). MPH significantly increases predictive saccades in ADHD when the direction and timing of the target movement is predictable but not when only the direction is predictable (<xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>).</p>
<p>The antisaccade task is a commonly used measure of response inhibition. Participants fixating a central target must resist looking toward a suddenly appearing peripheral target, and instead look to the mirror position on the opposite side of the screen. Children with ADHD have elevated rates of antisaccade errors (<xref ref-type="bibr" rid="bibr72-0269881112446531">Rommelse et al., 2008</xref>). There have been five studies of MPH effects on antisaccade performance in ADHD; three found MPH to reduce antisaccade errors (<xref ref-type="bibr" rid="bibr46-0269881112446531">Klein et al., 2002</xref>; <xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>) and two found no effect on errors (<xref ref-type="bibr" rid="bibr4-0269881112446531">Aman et al., 1998</xref>; <xref ref-type="bibr" rid="bibr59-0269881112446531">Mostofsky et al., 2001</xref>). Four studies looked at correct antisaccade latency (<xref ref-type="bibr" rid="bibr46-0269881112446531">Klein et al., 2002</xref>; <xref ref-type="bibr" rid="bibr59-0269881112446531">Mostofsky et al., 2001</xref>; <xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>) and two of these found MPH to reduce correct antisaccade latency (<xref ref-type="bibr" rid="bibr46-0269881112446531">Klein et al., 2002</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>), while one found this effect for gap trials only (<xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>). Thus MPH has a variable effect on antisaccade errors and latency in ADHD.</p>
<p>An inverted-U relationship between baseline performance and MPH effects on cognition has been suggested in some studies (<xref ref-type="bibr" rid="bibr23-0269881112446531">Engert et al., 2009</xref>; <xref ref-type="bibr" rid="bibr57-0269881112446531">Mehta et al., 2000</xref>). This relationship means that in individuals with lower baseline performance MPH may improve cognition, while in individuals with normal performance at baseline, MPH could have no effect or even disrupt cognitive performance. Thus, MPH effects on eye movements in healthy adults could differ from those in ADHD.</p>
<p>No studies have examined the effect of MPH on oculomotor performance in healthy adults. In the current study, we examined the effects of MPH on visually-guided saccades, smooth pursuit, predictive saccades and antisaccades. If the effect of MPH is independent of baseline performance, effects should be similar to those seen in ADHD, that is, MPH should reduce visually-guided saccade latency, improve smooth pursuit, increase predictive saccades when target movement is completely predictable but not when only direction is predictable, and potentially reduce antisaccade errors and latency. However, if an inverted-U applies, then in healthy adults MPH effects may vary as a function of baseline performance, with initially better-performing participants showing no improvement or performance decrements.</p>
</sec>
<sec id="section2-0269881112446531" sec-type="materials|methods">
<title>Methods and materials</title>
<sec id="section3-0269881112446531">
<title>Subjects</title>
<p>Twenty-nine healthy, Caucasian males (age 26.2 ± 5.3 years) took part in the study. Participants underwent a medical exam and were free of current physical illness as well as a history of DSM-III Axis I diagnoses as assessed by the Diagnostic Interview Schedule Screening Interview (DISSI) (<xref ref-type="bibr" rid="bibr55-0269881112446531">Marcus et al., 1990</xref>). Additional exclusion criteria included drug use as determined by a urine test (Triage Screen for Drugs of Abuse, Biosite Diagnostics, San Diego, CA) and a first-degree relative with a diagnosis of schizophrenia or ADHD. Participants had normal or corrected-to-normal vision (Snellen chart). The study was approved by the Research Ethics Board of the McGill University Department of Psychology and the Institutional Review Board of the Douglas Mental Health University Institute. Participants provided written informed consent and were compensated for their time.</p>
</sec>
<sec id="section4-0269881112446531">
<title>Tasks</title>
<sec id="section5-0269881112446531">
<title>Eye movements</title>
<p>Tasks were presented on a 17-inch RGB monitor running at 135 Hz in a darkened room. The stimulus was a square subtending 0.5 × 0.5 degrees of visual angle presented on a black background. Eye movements were recorded from the dominant eye with an infrared pupil tracker (250 Hz) (Eyelink, SR Research, Mississauga, Ontario, Canada). Calibration was performed across 24° with a drift correction prior to each trial.</p>
</sec>
<sec id="section6-0269881112446531">
<title>Visually-guided saccades</title>
<p>The target was presented in the center of the monitor for 1000–2000 ms then stepped horizontally to one of four peripheral locations (±6º, ±12º) where it remained for 1000ms (<xref ref-type="bibr" rid="bibr25-0269881112446531">Ettinger et al., 2003</xref>). Each target location was presented 15 times in a random sequence. Dependent variables were saccade latency (ms), amplitude (degree) and peak velocity (degree/s).</p>
</sec>
<sec id="section7-0269881112446531">
<title>Smooth pursuit</title>
<p>A target moved horizontally at 0.4 Hz across 24º of visual angle with a sinusoidal velocity profile (<xref ref-type="bibr" rid="bibr18-0269881112446531">Dépatie et al., 2002</xref>). Participants were instructed to keep their gaze on the target. They performed four 30s blocks of pursuit. In two blocks, participants were asked to attend to a letter presented at the center of the target and press a button whenever it changed (monitoring condition). This manipulation enhances pursuit quality (<xref ref-type="bibr" rid="bibr84-0269881112446531">Sweeney et al., 1994</xref>). In two blocks, the target center did not change (no-monitoring condition). Dependent variables were pursuit gain (eye velocity/target velocity) and the total number of saccades (<xref ref-type="bibr" rid="bibr63-0269881112446531">O’Driscoll and Callahan, 2008</xref>).</p>
</sec>
<sec id="section8-0269881112446531">
<title>Predictive saccades</title>
<p>Participants tracked a target as it stepped at a frequency of 0.4Hz between -12º, 0º, and +12º. Four conditions were administered that manipulated the predictability of the direction and timing of target movement: completely predictable, direction predictable, timing predictable and a saccade control condition (<xref ref-type="bibr" rid="bibr28-0269881112446531">Gagnon et al., 2002</xref>). Direction of target movement from center was unpredictable in two conditions, but direction from the periphery (back to center) was always predictable. For conditions in which target timing was predictable, the duration of the target at each location was 625ms; otherwise, duration averaged 625 ms but varied between 500 and 750 ms. Each condition lasted 60s. Dependent variables were the percentage of predictive saccades (i.e. latency &lt; 70ms) and the latency, amplitude and peak velocity of both predictive and reflexive saccades.</p>
</sec>
<sec id="section9-0269881112446531">
<title>Antisaccades</title>
<p>This task was identical to the visually-guided saccade task except that participants were instructed to direct their gaze away from the peripheral target to the mirror location on the opposite side of the screen. Dependent variables were the percentage of errors, and the latency, amplitude and peak velocity of correct antisaccades.</p>
</sec></sec>
<sec id="section10-0269881112446531">
<title>Physiological measures</title>
<p>Blood pressure and pulse were measured immediately before capsule administration, and immediately before and after oculomotor testing. Samples of venous blood were taken immediately before and ≈ 2 h after capsule administration to calculate drug blood plasma levels.</p>
</sec>
<sec id="section11-0269881112446531">
<title>Procedures</title>
<p>Participants first underwent a screening session to determine eligibility and performed the tasks to reduce practice effects on the medication trial (<xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>). Participants also completed a number of self-report measures, the results of which have been reported elsewhere (<xref ref-type="bibr" rid="bibr24-0269881112446531">Ettinger et al., 2006</xref>).</p>
<p>A double-blind, placebo-controlled crossover trial was then administered approximately one week after the screening session with medication order (placebo or methylphenidate first) randomized across subjects. Upon arrival at the lab, a breathalyzer (Alco-Sensor IV, Intoximeters, Inc., Saint Louis, MO) and urine drug screen (Triage Screen for Drugs of Abuse, Biosite Diagnostics, San Diego, CA) were administered. Vital signs were assessed by a nurse before capsule administration (T0), immediately before task performance (T1 – i.e. 50 minutes post-capsule administration) and immediately after task performance (T2 – i.e. approximately 90 minutes post-capsule). On one occasion, a sample of venous blood was taken for DNA extraction. The genetic analyses have been reported elsewhere (<xref ref-type="bibr" rid="bibr24-0269881112446531">Ettinger et al., 2006</xref>).</p>
<p>MPH (20mg, average dose 0.26 mg/kg) and placebo were administered orally in identical capsules. This dose is clinically relevant and has improved cognition in healthy individuals in previous studies without inducing negative side effects (e.g. <xref ref-type="bibr" rid="bibr13-0269881112446531">Camp-Bruno and Herting, 1994</xref>; <xref ref-type="bibr" rid="bibr22-0269881112446531">Elliott et al., 1997</xref>).</p>
<p>Placebo and drug sessions took place between six and 11 days apart (mode seven days) with testing conducted at the same time on both days.</p>
</sec>
<sec id="section12-0269881112446531">
<title>Eye movement coding</title>
<p>Eye movements were parsed with a semi-automated custom analysis software package (SR Research, Osgoode, ON) and checked visually. Saccades were identified based on velocity (&gt;22°/s) and acceleration (&gt;4000°/s<sup>2</sup>) criteria. Saccades were excluded from analyses according to published criteria (<xref ref-type="bibr" rid="bibr18-0269881112446531">Dépatie et al., 2002</xref>); saccades with latency &lt;70 ms were retained in the predictive saccade analyses (<xref ref-type="bibr" rid="bibr28-0269881112446531">Gagnon et al., 2002</xref>). In the predictive saccade task, for each target step, the first saccade &gt; 3° in the direction of the target was selected. For the pursuit task, the first half cycle for all blocks was excluded as were blinks and the portion of the pursuit trace 200 ms before and after blinks. Analyses of pursuit excluded the turnaround.</p>
</sec>
<sec id="section13-0269881112446531">
<title>Statistical analysis</title>
<p>Data were winsorized, such that values &gt; 3SD from the mean were replaced with the closest value, a process that retains rank order while removing the influence of extreme outliers. Analyses were conducted using PASW 18 statistical software (SPSS Inc.). Variables were assessed for normality using a one-sample Kolmogorov–Smirnov test; non-parametric tests were used for variables that were not normally distributed.</p>
<p>Eye movement variables were analyzed using two-way mixed ANOVAs with Drug as the within-subject factor, and Order as the between-subjects factor. For the smooth pursuit task, Condition (monitoring versus no monitoring) and Trace Half (first versus second half of each 30 second trace) were included as within-subject factors. Order effects are mentioned only when significant. For the predictive saccade tasks, Saccade Type (predictive versus reflexive) was also included as a within-subject factor. Expected main effects of saccade type on amplitude and peak velocity were obtained but are not reported except where they interacted with Group or Drug.</p>
<p>To investigate the possibility of an inverted-U response to MPH, participants were dichotomized into high/low performance at baseline using a median split of each of the major dependent variables. The two groups formed by baseline performance on a given task were then used as a between-subject factor in the analyses of that task.</p>
<p>For variables that showed a significant effect of MPH, we evaluated whether or not the magnitude of change in performance on the task was related to the magnitude of change in performance on other tasks, using Pearson’s <italic>r</italic>.</p>
<p>Mean arterial blood pressure (MAP) was calculated using the formula MAP = BP<sub>dia</sub> + 1/3 (BP<sub>sys</sub> – BP<sub>dia</sub>), where BP<sub>dia</sub> is diastolic blood pressure and BP<sub>sys</sub> is systolic blood pressure. MAP and heart rate were analyzed separately using mixed ANOVA models with Time (T0, T1 and T2) and Drug (methylphenidate, placebo) as within-subject factors and Order (methylphenidate-first, placebo-first) as the between-subject factor. Effects of Time are reported if they interact with Drug.</p>
<p>Data are reported as mean ± standard deviation in descriptive statistics. Statistical tests were two tailed.</p>
</sec></sec>
<sec id="section14-0269881112446531" sec-type="results">
<title>Results</title>
<sec id="section15-0269881112446531">
<title>Visually-guided saccade task</title>
<p>Latency of visually-guided saccades decreased significantly on MPH (Drug: <italic>F</italic>(1,25)= 9.8, <italic>p</italic>=0.004; Placebo 166.1± 20.4; MPH: 159.7 ± 18.6). Amplitude and peak velocity of visually-guided saccades were not changed by Drug (<italic>p</italic>&gt;0.2).</p>
</sec>
<sec id="section16-0269881112446531">
<title>Smooth pursuit</title>
<p>MPH significantly increased pursuit gain (Drug: <italic>F</italic>(1,27)=21.1, <italic>p</italic>&lt;0.001; Placebo: 0.92±0.04 MPH:0.94±0.03) and decreased the number of saccades during pursuit (Drug: <italic>F</italic>(1,24)=18.2, <italic>p</italic>&lt;0.001; Placebo: 27.6± 6.7, MPH: 23.4± 6.5). (<xref ref-type="fig" rid="fig1-0269881112446531">Figure 1</xref>) (Saccade rate (number of saccades/seconds of data) yielded the same results). Smooth pursuit was poorer in the second half of each trace, with lower gain and more saccades in the second half of the trace than the first (Task Half on Gain, <italic>F</italic>(1,27)=13.5, <italic>p</italic>=0.001; Task Half on Saccades: <italic>F</italic>(1,27) = 27.7, <italic>p</italic>&lt;0.001). However, Drug did not interact with Task Half; thus, MPH did not improve pursuit by preventing a decline in performance with time.</p>
<fig id="fig1-0269881112446531" position="float">
<label>Figure 1.</label>
<caption>
<p>Effect of MPH on smooth pursuit. Data are mean ± SE. Methylphenidate (MPH) significantly increased pursuit gain and decreased the number of saccades during pursuit.</p>
</caption>
<graphic xlink:href="10.1177_0269881112446531-fig1.tif"/>
</fig>
</sec>
<sec id="section17-0269881112446531">
<title>Predictive saccades</title>
<sec id="section18-0269881112446531">
<title>Completely predictable task</title>
<p>Percentage of predictive saccades significantly increased with MPH (Drug, <italic>F</italic>(1,26) = 10.2, <italic>p</italic>=0.004; Placebo: 65.9%±22.3%, MPH: 74.1%±14.6%) (<xref ref-type="fig" rid="fig2-0269881112446531">Figure 2</xref>).</p>
<fig id="fig2-0269881112446531" position="float">
<label>Figure 2.</label>
<caption>
<p>Effect of methylphenidate (MPH) on predictive saccades. Data are mean ± SE. MPH significantly increased the percentage of predictive saccades in conditions with predictable timing (completely predictable task (CPT) and timing predictable task (TPT)) but not in conditions without predictable timing (direction predictable task (DPT) and saccade control task (SCT)).</p>
</caption>
<graphic xlink:href="10.1177_0269881112446531-fig2.tif"/>
</fig>
<p>For saccade latency, there was a three-way interaction between Drug, Saccade Type and Order (<italic>F</italic>(1,26) = 5.0, <italic>p</italic> = 0.034). This interaction reflected the fact that for reflexive saccades, but not for predictive saccades, drug-placebo differences were larger when MPH was received second (Placebo: 115.6±18.0, MPH:104.3±11.2) than when it was received first (Placebo: 108.2±16.6, MPH: 111.6±17.1, Drug by Order <italic>F</italic>(1,26)=5.12, <italic>p</italic>=0.032). Participants in the two orders did not differ in their reflexive or predictive saccade latencies on or off drug, or in session 1 or session 2.</p>
<p>Saccade amplitudes were unaffected by Drug.</p>
<p>Peak velocity of saccades increased on MPH (Drug: <italic>F</italic>(1,26)=7.7, <italic>p</italic>=0.01; MPH: 416.9±59.2; Placebo: 399.6±63.0). There was no interaction with Saccade Type.</p>
</sec>
<sec id="section19-0269881112446531">
<title>Direction predictable task</title>
<p>Percentage of predictive saccades did not change in this condition with MPH (<italic>p</italic>&gt;0.8) (<xref ref-type="fig" rid="fig2-0269881112446531">Figure 2</xref>). Saccade latencies in this task were also unaffected by Drug (<italic>p</italic>&gt;0.2)</p>
<p>For saccade amplitude, there was a significant Drug by Saccade Type interaction (<italic>F</italic>(1,27)=6.5, <italic>p</italic>=0.016). This reflected the fact that MPH increased predictive saccade amplitude slightly (<italic>t</italic>(28)=-1.13, <italic>p</italic>=0.2; Placebo: 10.4±1.3, MPH: 10.7±1.2) while decreasing reflexive saccade amplitude slightly (<italic>t</italic>(28)=0.24, <italic>p</italic>=0.8, Placebo: 11.6±0.8, MPH: 11.5±0.9), although both effects were non-significant in post-hoc comparisons.</p>
<p>Peak velocity significantly increased on MPH (<italic>F</italic>(1,27)=8.6, <italic>p</italic>=0.007). This effect was qualified by a significant Drug × Saccade Type interaction (<italic>F</italic>(1,27)=17.6, <italic>p</italic>&lt;0.001). MPH significantly increased predictive saccade peak velocity (<italic>t</italic>(28)=-3.7, <italic>p</italic>=0.001, Placebo: 349.4±69.6, MPH: 382.4±70.1) without affecting reflexive saccade peak velocity (<italic>t</italic>(28)=-1.25, <italic>p</italic>=0.2. Placebo: 425.02±56.7, MPH: 431.6±59.2).</p>
</sec>
<sec id="section20-0269881112446531">
<title>Timing predictable task</title>
<p>Percentage of predictive saccades significantly increased on MPH compared with placebo in the timing predictable task (Drug: <italic>F</italic>(1,27) = 4.9, <italic>p</italic>=0.035; Placebo: 27.4% ± 17.4%, MPH: 31.8% ± 15.9%) (<xref ref-type="fig" rid="fig2-0269881112446531">Figure 2</xref>). Saccade latency and amplitude were unaffected by Drug (<italic>p</italic>&gt;0.09).</p>
<p>For peak velocity, there was a significant Drug by Saccade type interaction (<italic>F</italic>(1,25)=18.9, <italic>p</italic>&lt;0.001) indicating that MPH significantly increased the peak velocity of predictive saccades (<italic>t</italic>(26)=-3.13, <italic>p</italic>=0.004; Placebo: 371.6±70.7, MPH: 401.4±68.1) without affecting that of reflexive saccades (<italic>t</italic>(28)=-0.28, <italic>p</italic>=0.8; Placebo: 435.8±61.5, MPH:437.5±53.6).</p>
</sec>
<sec id="section21-0269881112446531">
<title>Saccade control task</title>
<p>In the control task, percentage of predictive saccades did not change with MPH (<italic>p</italic>&gt;0.16) (<xref ref-type="fig" rid="fig2-0269881112446531">Figure 2</xref>).</p>
<p>For latency, there was a three-way interaction of Drug, Saccade Type and Order (<italic>F</italic>(1,25)=4.6, <italic>p</italic>=0.042). This reflected the fact that predictive saccades but not reflexive saccades were more temporally accurate in the second session than the first, regardless of which pill was administered (i.e. practice effect) (Pred Sac Latency first session: -50.3±62; second session -28.9 ±59.7; paired <italic>t</italic>(26)=, <italic>p</italic>= 0.038). When the target was in the periphery about to move back to the center, participants would sometimes anticipate the move, making a predictive saccade. Increased exposure to the target allowed anticipations in the second session to be more accurate than those in the first, without affecting their number, and without affecting reflexive saccades.</p>
<p>For saccade amplitude, there was no effect of Drug.</p>
<p>For peak velocity, there was a Drug by Saccade Type interaction (<italic>F</italic>(1,25)=6.33, <italic>p</italic>=0.019). MPH significantly increased the peak velocity of predictive saccades (<italic>t</italic>(26)-2.42, <italic>p</italic>=0.02; Placebo: 361.8±85.7, MPH: 393.6±65.7) without affecting the peak velocity of reflexive saccades (<italic>t</italic>(26)= -0.57, <italic>p</italic>=0.57; Placebo: 431.4±60.2, MPH: 434.8±52.6).</p>
</sec></sec>
<sec id="section22-0269881112446531">
<title>Antisaccades</title>
<p>There were no significant effects of Drug on antisaccade errors, latency, amplitude or peak velocity (<italic>p</italic>s &gt; 0.1) (<xref ref-type="table" rid="table1-0269881112446531">Table 1</xref>).</p>
<table-wrap id="table1-0269881112446531" position="float">
<label>Table 1.</label>
<caption>
<p>MPH effects on eye movements.</p>
</caption>
<graphic alternate-form-of="table1-0269881112446531" xlink:href="10.1177_0269881112446531-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="7">a) Basic oculomotor tasks</th>
</tr>
<tr>
<th colspan="7"><hr/></th>
</tr>
<tr>
<th align="left">Task</th>
<th align="left" colspan="2">Latency<hr/></th>
<th align="left" colspan="2">Amplitude<hr/></th>
<th align="left" colspan="2">Peak velocity<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th align="left">Placebo</th>
<th align="left">MPH</th>
</tr>
</thead>
<tbody>
<tr>
<td>VGS</td>
<td><bold>166.1±20.4</bold></td>
<td><bold>159.7±18.6</bold></td>
<td>9.2±0.7</td>
<td>9.3±0.8</td>
<td>356.8±56.1</td>
<td>362.1±55.4</td>
</tr>
<tr>
<th colspan="7"><hr/></th>
</tr>
<tr>
<th/>
<th align="left" colspan="2">Gain<hr/></th>
<th/>
<th align="left" colspan="3">Total Saccades<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
</tr>
<tr>
<th colspan="7"><hr/></th>
</tr>
<tr>
<td>Pursuit</td>
<td><bold>0.92±0.04</bold></td>
<td><bold>0.94±0.03</bold></td>
<td/>
<td><bold>27.59 ± 6.7</bold></td>
<td><bold>23.44±6.5</bold></td>
<td/>
</tr>
</tbody>
</table>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="15">b) Higher-order oculomotor tasks</th>
</tr>
<tr>
<th colspan="15"><hr/></th>
</tr>
<tr>
<th/>
<th align="left" colspan="2">Percent predictive saccades<hr/></th>
<th align="left" colspan="4">Latency<hr/></th>
<th align="left" colspan="4">Amplitude<hr/></th>
<th align="left" colspan="4">Peak velocity<hr/></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="left" colspan="2">Reflexive<hr/></th>
<th align="left" colspan="2">Predictive<hr/></th>
<th align="left" colspan="2">Reflexive<hr/></th>
<th align="left" colspan="2">Predictive<hr/></th>
<th align="left" colspan="2">Reflexive<hr/></th>
<th align="left" colspan="2">Predictive<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th align="left">P</th>
<th align="left">D</th>
<th align="left">P</th>
<th align="left">D</th>
<th align="left">P</th>
<th align="left">D</th>
<th align="left">P</th>
<th align="left">D</th>
<th align="left">P</th>
<th align="left">D</th>
<th align="left">P</th>
<th align="left">D</th>
</tr>
</thead>
<tbody>
<tr>
<td>CPT</td>
<td><bold>65.9±22.3</bold></td>
<td><bold>74.1±14.6</bold></td>
<td>111.9±17.3</td>
<td>107.9±14.7</td>
<td>-61.9±79.6</td>
<td>-67.6±54.4</td>
<td>11.5±0.9</td>
<td>11.6±0.8</td>
<td>10.8±1.2</td>
<td>11.1±1.1</td>
<td><bold>430.8±65.6</bold></td>
<td><bold>444.2±58.7</bold></td>
<td><bold>367.9±68.2</bold></td>
<td><bold>392.0±64.1</bold></td>
</tr>
<tr>
<td>DPT</td>
<td>58.2±22.4</td>
<td>59.6±22.4</td>
<td>112.9±16.6</td>
<td>111.9±14.8</td>
<td>-67.1±64.0</td>
<td>-70.0±62.8</td>
<td>11.6±0.8</td>
<td>11.5±0.9</td>
<td>10.4±1.3</td>
<td>10.7±1.2</td>
<td>425.1±57.7</td>
<td>431.6±60.2</td>
<td><bold>349.6±69.6</bold></td>
<td><bold>382.4±70.1</bold></td>
</tr>
<tr>
<td>TPT</td>
<td><bold>27.4±17.4</bold></td>
<td><bold>31.8±15.8</bold></td>
<td>122.3±15.1</td>
<td>121.9±14.7</td>
<td>-16.3±61.2</td>
<td>-19.7±59.9</td>
<td>11.8±0.7</td>
<td>11.7±0.9</td>
<td>10.8±0.9</td>
<td>10.9±1.1</td>
<td>438.3±63.7</td>
<td>436.5±55.7</td>
<td><bold>371.3±71.5</bold></td>
<td><bold>400.9±68.2</bold></td>
</tr>
<tr>
<td>SCT</td>
<td>34.5±20.3</td>
<td>34.7±15.6</td>
<td>125.3±15.1</td>
<td>122.8±13.5</td>
<td>-45.6±54.3</td>
<td>-38.7±65.4</td>
<td>11.7±0.7</td>
<td>11.7±0.8</td>
<td>10.4±1.3</td>
<td>10.7±1.1</td>
<td>431.6±60.1</td>
<td>434.9±52.5</td>
<td><bold>362.1±85.4</bold></td>
<td><bold>394.0±64.9</bold></td>
</tr>
<tr>
<th colspan="15"><hr/></th>
</tr>
<tr>
<th align="left">Task</th>
<th/>
<th align="left" colspan="2">Percent error<hr/></th>
<th/>
<th align="left" colspan="2">Latency<hr/></th>
<th/>
<th align="left" colspan="2">Amplitude<hr/></th>
<th/>
<th align="left" colspan="4">Peak velocity<hr/></th>
</tr>
<tr>
<th/>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
<th align="left">Placebo</th>
<th align="left">MPH</th>
<th/>
<th/>
</tr>
<tr>
<th colspan="15"><hr/></th>
</tr>
<tr>
<td>AntiS.</td>
<td/>
<td>26±17</td>
<td>27±16</td>
<td/>
<td>270.6±42.5</td>
<td>265.5±35.9</td>
<td/>
<td>7.6±1.5</td>
<td>7.4±1.5</td>
<td/>
<td>313.7±55.9</td>
<td>321.5±54.4</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269881112446531">
<p>Data represent mean <bold>±</bold> SD. Significant MPH-placebo comparisons are in bold. VGS: visually-guided saccade task; Pursuit: smooth pursuit task. CPT: completely predictable task; DPT: direction predictable task; TPT: timing predictable task; SCT: saccade control task; AntiS: antisaccade task; MPH: methylphenidate; P: on placebo; D: on drug. Reflexive and Predictive refer to different saccade types generated in each condition (see <italic>Methods and materials</italic>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section23-0269881112446531">
<title>Drug response as a function of baseline performance</title>
<p>There were no significant Group by Drug interactions (all <italic>p</italic>s &gt; 0.1). Thus, drug effects did not depend on baseline performance.</p>
</sec>
<sec id="section24-0269881112446531">
<title>Correlations</title>
<p>The magnitude of change was calculated for each subject for variables that changed significantly with MPH (visually-guided saccade latency, smooth pursuit gain and total saccades during pursuit, proportion of predictive saccades in the completely predictable and timing predictable tasks, and peak velocity of predictive saccades). The only significant correlation was between change in smooth pursuit gain and change in the number of saccades on this task (<italic>r</italic> = -0.57, <italic>p</italic> = 0.001).</p>
</sec>
<sec id="section25-0269881112446531">
<title>Physiological variables</title>
<p>For MAP and for Heart Rate, there was no effect of Drug. Heart rates were higher on the first day of testing (Drug × Order: <italic>F</italic>(1,26)=5.09, <italic>p</italic>=0.03); thus, in those who received placebo first, heart rate declined on MPH (Day 2) (Placebo: 66.4±7.8, MPH: 64.5±7.6), while in those who received MPH first, heart rate declined on Placebo (Day 2) (Placebo: 68.8±7.8, MPH: 71.8±7.6).</p>
</sec></sec>
<sec id="section26-0269881112446531" sec-type="discussion">
<title>Discussion</title>
<p>Our results provide the first evidence of MPH effects on oculomotor function in healthy controls. Our principal findings were that MPH: 1) decreased saccade latency in the visually-guided saccade task; 2) improved smooth pursuit performance; 3) increased the proportion of predictive saccades in conditions where target timing was predictable; 4) increased the peak velocity of predictive saccades in the predictive saccade task, generally without affecting the peak velocity of reflexive saccades; and 5) had no effect on antisaccade performance. The general pattern of MPH effects in healthy adults is similar to that seen in children with ADHD. A possible exception was the antisaccade task where MPH had no effect in healthy adults, whereas in some studies of ADHD it has improved inhibition.</p>
<p>MPH-related reductions of visually-guided saccade latency could reflect the drug’s action in the caudate nucleus. MPH’s primary site of action is the striatum, where it binds to the DA transporter (<xref ref-type="bibr" rid="bibr19-0269881112446531">Ding et al., 1997</xref>; <xref ref-type="bibr" rid="bibr89-0269881112446531">Volkow et al., 1995</xref>), increasing DA levels (<xref ref-type="bibr" rid="bibr91-0269881112446531">Volkow et al., 2001</xref>). The caudate is involved in saccadic reaction time through a series of connections that gate firing in the motor output layers of the superior colliculus (<xref ref-type="bibr" rid="bibr31-0269881112446531">Hikosaka and Wurtz, 1983</xref>; <xref ref-type="bibr" rid="bibr30-0269881112446531">Hikosaka et al., 2000</xref>; <xref ref-type="bibr" rid="bibr39-0269881112446531">Jayaraman et al., 1977</xref>). In the direct pathway, activation of the caudate inhibits the substantia nigra pars reticulata (SNpr) which tonically inhibits the output layers of the superior colliculus; thus, in this pathway, caudate activation releases the SC from tonic inhibition and facilitates saccade release (<xref ref-type="bibr" rid="bibr30-0269881112446531">Hikosaka et al., 2000</xref>). Consistent with this, shorter saccadic reaction times are associated with higher caudate neuron activity in non-human primates (<xref ref-type="bibr" rid="bibr30-0269881112446531">Hikosaka et al., 2000</xref>; <xref ref-type="bibr" rid="bibr37-0269881112446531">Itoh et al., 2003</xref>; <xref ref-type="bibr" rid="bibr94-0269881112446531">Watanabe and Munoz, 2009</xref>; <xref ref-type="bibr" rid="bibr93-0269881112446531">Watanabe et al., 2003</xref>). Although alerting effects could also be invoked to explain the change in visually-guided saccade latency, alerting has been reported to reduce latencies of both prosaccades and antisaccades (<xref ref-type="bibr" rid="bibr49-0269881112446531">Kristjansson et al., 2004</xref>), which was not the pattern observed here.</p>
<p>Peak velocity changes with MPH could also be attributed to drug action on DA in basal ganglia. Increasing basal ganglia activity in non-human primates has been reported to increase peak velocity of saccades and to have a greater effect on voluntary than on reflexive saccades (<xref ref-type="bibr" rid="bibr32-0269881112446531">Hikosaka and Wurtz, 1985</xref>; <xref ref-type="bibr" rid="bibr48-0269881112446531">Kori et al., 1995</xref>), consistent with what we found here. A greater effect of dopamine manipulations on voluntary saccades has also been reported in humans (<xref ref-type="bibr" rid="bibr82-0269881112446531">Straube et al., 1999</xref>). In non-human primates, peak velocity can be increased and saccade latency decreased by reward (<xref ref-type="bibr" rid="bibr43-0269881112446531">Kawagoe et al., 1998</xref>; <xref ref-type="bibr" rid="bibr85-0269881112446531">Takikawa et al., 2002</xref>) and these changes have been shown to be modulated by dopamine in the caudate (<xref ref-type="bibr" rid="bibr62-0269881112446531">Nakamura and Hikosaka, 2006</xref>). MPH-related changes in saccade kinetics resemble reward-related changes and may have similar neural substrates.</p>
<p>The MPH-induced improvement in smooth pursuit in healthy adults is consistent with two previous studies in ADHD (<xref ref-type="bibr" rid="bibr6-0269881112446531">Bala et al., 1981</xref>; <xref ref-type="bibr" rid="bibr12-0269881112446531">Bylsma and Pivik, 1989</xref>). In controls, MPH effects on pursuit have not been studied but dextroamphetamine, which is similar pharmacologically, has not affected pursuit. However, the only studies done had very low power (five and 11 participants) (<xref ref-type="bibr" rid="bibr54-0269881112446531">Malaspina et al., 1994</xref>; <xref ref-type="bibr" rid="bibr86-0269881112446531">Tedeschi et al., 1983</xref>). Nicotine, which increases DA indirectly (<xref ref-type="bibr" rid="bibr35-0269881112446531">Imperato et al., 1986</xref>; <xref ref-type="bibr" rid="bibr68-0269881112446531">Pierce and Kumaresan, 2006</xref>), has had similar effects on pursuit in controls to what we find here with MPH (i.e. increased gain, reduced saccades (<xref ref-type="bibr" rid="bibr18-0269881112446531">Dépatie et al., 2002</xref>; <xref ref-type="bibr" rid="bibr21-0269881112446531">Domino et al., 1997</xref>; <xref ref-type="bibr" rid="bibr78-0269881112446531">Sherr et al., 2002</xref>; but see also <xref ref-type="bibr" rid="bibr66-0269881112446531">Olincy et al., 1998</xref>)).</p>
<p>In the predictive saccade task, MPH increased the proportion of predictive saccades selectively in conditions in which timing was predictable. (The direction of Target steps from the periphery was back to center so some predictive saccades could be made in all conditions). The MPH-related increases in predictive saccades could reflect an effect on timing since the subject can use temporal information to better synchronize saccade release with target movement. MPH administration has been reported to improve performance in some subsecond timing tasks in ADHD. For example, MPH has improved performance on the predictive saccade task (<xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>), on manual measures of sensorimotor synchronization (<xref ref-type="bibr" rid="bibr73-0269881112446531">Rubia et al., 2003</xref>) and on a finger tapping task in which subjects were required to generate movements at a specified rhythm (<xref ref-type="bibr" rid="bibr9-0269881112446531">Ben-Pazi et al., 2006</xref>).</p>
<p>Subsecond timing is thought to be supported by the basal ganglia and cerebellum (<xref ref-type="bibr" rid="bibr95-0269881112446531">Wiener et al., 2010</xref>) and both these regions are involved in predictive saccades (<xref ref-type="bibr" rid="bibr28-0269881112446531">Gagnon et al., 2002</xref>). Patients with cerebellar involvement show reduced ability to use predictable timing to shorten saccade latency (<xref ref-type="bibr" rid="bibr36-0269881112446531">Isotalo et al., 1995</xref>; <xref ref-type="bibr" rid="bibr61-0269881112446531">Nagel and Zangemeister, 2003</xref>; <xref ref-type="bibr" rid="bibr74-0269881112446531">Sailer et al., 2005</xref>; but see <xref ref-type="bibr" rid="bibr51-0269881112446531">Lasker et al., 2005</xref>) and imaging studies in humans highlight the importance of cerebellum in timing predictable saccade tasks (<xref ref-type="bibr" rid="bibr28-0269881112446531">Gagnon et al., 2002</xref>; <xref ref-type="bibr" rid="bibr65-0269881112446531">O’Driscoll et al., 2000</xref>; <xref ref-type="bibr" rid="bibr79-0269881112446531">Simó et al., 2005</xref>). With respect to basal ganglia, evidence of deficits in predictive saccade timing in Parkinson’s patients is mixed (<xref ref-type="bibr" rid="bibr16-0269881112446531">Crawford et al., 1989</xref>; <xref ref-type="bibr" rid="bibr67-0269881112446531">O’Sullivan et al., 1997</xref>; <xref ref-type="bibr" rid="bibr88-0269881112446531">Ventre et al., 1992</xref>), but putamen is significantly activated during fully predictive and timing predictable saccades (<xref ref-type="bibr" rid="bibr28-0269881112446531">Gagnon et al., 2002</xref>). A recent study in monkeys found neurons in caudate to encode time periods ranging from 150 to 500 ms when saccades were performed without explicit timing requirements (<xref ref-type="bibr" rid="bibr40-0269881112446531">Jin et al., 2009</xref>).</p>
<p>The effects of MPH on timing performance might be mediated via action on the cerebellum. MPH increases blood flow and glucose metabolism in cerebellum in healthy adults (<xref ref-type="bibr" rid="bibr57-0269881112446531">Mehta et al., 2000</xref>; <xref ref-type="bibr" rid="bibr87-0269881112446531">Udo de Haes, et al., 2007</xref>; <xref ref-type="bibr" rid="bibr90-0269881112446531">Volkow et al., 1997</xref>) and in individuals with ADHD (<xref ref-type="bibr" rid="bibr5-0269881112446531">Anderson et al., 2002</xref>; <xref ref-type="bibr" rid="bibr56-0269881112446531">Matochik et al., 1993</xref>; <xref ref-type="bibr" rid="bibr76-0269881112446531">Schweitzer et al., 2003</xref>), possibly through action on DA. The ventral tegmental area has extensive projections to the granule and Purkinje cell layers of the cerebellum (<xref ref-type="bibr" rid="bibr33-0269881112446531">Ikai et al., 1992</xref>; <xref ref-type="bibr" rid="bibr80-0269881112446531">Simon et al., 1979</xref>), which have DA receptors (<xref ref-type="bibr" rid="bibr44-0269881112446531">Khan et al., 1998</xref>). Dopamine transporter (DAT) immunoreactive axons have also been found in the vermis of the primate cerebellum (<xref ref-type="bibr" rid="bibr58-0269881112446531">Melchitzky and Lewis, 2000</xref>), a brain area involved in eye movements.</p>
<p>Few studies have looked at the behavioral effect of cerebellar DA. In rats, microinjections of DA agonists and antagonists into the cerebellum activate or inhibit locomotor activity in a dose dependent manner (<xref ref-type="bibr" rid="bibr7-0269881112446531">Barik and de Beaurepaire, 1996</xref>; <xref ref-type="bibr" rid="bibr47-0269881112446531">Kolasiewicz et al., 2008</xref>). The distribution of DA receptors in the cerebellum suggests that this neurotransmitter may modulate cerebellar long-term depression, which plays an important role in motor timing (<xref ref-type="bibr" rid="bibr2-0269881112446531">Alder and Barbas, 1995</xref>; <xref ref-type="bibr" rid="bibr45-0269881112446531">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bibr75-0269881112446531">Schweighofer et al., 2004</xref>). Both DA and NA modulate climbing fiber firing, which impacts long-term depression and long-term potentiation (<xref ref-type="bibr" rid="bibr14-0269881112446531">Carey and Regehr, 2009</xref>).</p>
<p>MPH did not affect antisaccades. Previous studies of ADHD suggested MPH might reduce antisaccade latencies (<xref ref-type="bibr" rid="bibr46-0269881112446531">Klein et al., 2002</xref>; <xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>) and errors (<xref ref-type="bibr" rid="bibr4-0269881112446531">Aman et al., 1998</xref>; <xref ref-type="bibr" rid="bibr59-0269881112446531">Mostofsky et al., 2001</xref>; <xref ref-type="bibr" rid="bibr60-0269881112446531">Munoz et al., 1999</xref>; <xref ref-type="bibr" rid="bibr64-0269881112446531">O’Driscoll et al., 2005</xref>), although results are divided. In an earlier study, we found that dextroamphetamine reduced antisaccade errors and also affected latency as a function of baseline performance (<xref ref-type="bibr" rid="bibr3-0269881112446531">Allman et al., 2010</xref>). These effects were not observed here with MPH. Differences in the findings for the two drugs could reflect differences in the antisaccade tasks used. In previous studies only one target location was used in each hemifield. In the current study, we used two per hemifield. Additional target locations affect saccade latency and error rate (<xref ref-type="bibr" rid="bibr8-0269881112446531">Bell et al., 2000</xref>; <xref ref-type="bibr" rid="bibr17-0269881112446531">Delaney and Roberts, 1999</xref>; <xref ref-type="bibr" rid="bibr26-0269881112446531">Evdokimidis et al., 2006</xref>; <xref ref-type="bibr" rid="bibr81-0269881112446531">Smyrnis et al., 2002</xref>). The requirement to attend to more potential target locations could affect the role of DA in the task by shifting the cognitive balance away from a focus on internal goals to guide behavior toward the need to flexibly attend to environmental events (<xref ref-type="bibr" rid="bibr11-0269881112446531">Bilder et al., 2004</xref>; <xref ref-type="bibr" rid="bibr77-0269881112446531">Seamans and Yang, 2004</xref>). These competing cognitive states are thought to differentially involve D1 versus D2 receptors and tonic versus phasic DA release, and could influence drug effects on task performance.</p>
<p>A strength but also a limitation of the current study is the homogeneity of the sample. Because this was the first study of MPH effects on eye movements in healthy adults, we chose a homogeneous group to decrease population-related variance that might reduce drug-related signal. As a result, the extent to which the results apply to females, other racial groups and other age ranges is unclear. An additional limitation of the study was the use of a single, low dose of MPH. It is possible that at a higher dose, an interaction between baseline performance and drug response might have been observed, or that cognitive effects that were not obtained might have been found. However, the dose we used has been shown to significantly increase extracellular dopamine in healthy adults (<xref ref-type="bibr" rid="bibr92-0269881112446531">Volkow et al., 2004</xref>) and to affect other aspects of neuropsychological performance in previous studies of young adults (<xref ref-type="bibr" rid="bibr13-0269881112446531">Camp-Bruno and Hertig, 1994</xref>; <xref ref-type="bibr" rid="bibr22-0269881112446531">Elliott et al., 1997</xref>).</p>
<p>To conclude, low dose MPH significantly improves some cognitive and motor functions in adults with intact baseline performance. MPH effects in healthy adults were similar to those observed in ADHD. The selective improvements in predictive saccade conditions with predictable timing is consistent with MPH-related improvements in timing functions.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work was supported by an NSERC Doctoral Fellowship and an NSERC Julie Payette Master’s Award (AA), a Tomlinson Postdoctoral Fellowship from McGill University (UE), a grant from the GW Stairs Memorial Fund (UE), a William Dawson Scholar Award (GO’D), an operating grant from the CIHR (GO’D) (Grant number MOP-44061) and funding from the Deutsche Forschungsgemeinschaft (ET 31/2-1) (UE).</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Advokat</surname><given-names>CD</given-names></name>
<name><surname>Guidry</surname><given-names>D</given-names></name>
<name><surname>Martino</surname><given-names>L</given-names></name>
</person-group> (<year>2008</year>) <article-title>Licit and illicit use of medications for Attention-Deficit Hyperactivity Disorder in undergraduate college students</article-title>. <source>J Am Coll Health</source> <volume>56</volume>: <fpage>601</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr2-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alder</surname><given-names>R</given-names></name>
<name><surname>Barbas</surname><given-names>H</given-names></name>
</person-group> (<year>1995</year>) <article-title>Complementary distribution of the phosphoproteins DARPP-32 and I-1 in the cerebellar system</article-title>. <source>Neuroreport</source> <volume>6</volume>: <fpage>2368</fpage>–<lpage>2372</lpage>.</citation>
</ref>
<ref id="bibr3-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Allman</surname><given-names>A-A</given-names></name>
<name><surname>Benkelfat</surname><given-names>C</given-names></name>
<name><surname>Durand</surname><given-names>F</given-names></name><etal/>
</person-group>. (<year>2010</year>) <article-title>Effect of d-amphetamine on inhibition and motor planning as a function of baseline performance</article-title>. <source>Psychopharmacology</source> <volume>211</volume>: <fpage>423</fpage>–<lpage>433</lpage>.</citation>
</ref>
<ref id="bibr4-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aman</surname><given-names>CJ</given-names></name>
<name><surname>Roberts</surname><given-names>RJ</given-names><suffix>Jr</suffix></name>
<name><surname>Pennington</surname><given-names>BF</given-names></name>
</person-group> (<year>1998</year>) <article-title>A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: Frontal lobe versus right parietal lobe theories</article-title>. <source>Dev Psychol</source> <volume>34</volume>: <fpage>956</fpage>–<lpage>969</lpage>.</citation>
</ref>
<ref id="bibr5-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>CM</given-names></name>
<name><surname>Polcari</surname><given-names>A</given-names></name>
<name><surname>Lowen</surname><given-names>SB</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD</article-title>. <source>Am J Psychiatry</source> <volume>159</volume>: <fpage>1322</fpage>–<lpage>1328</lpage>.</citation>
</ref>
<ref id="bibr6-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bala</surname><given-names>SP</given-names></name>
<name><surname>Cohen</surname><given-names>B</given-names></name>
<name><surname>Morris</surname><given-names>AG</given-names></name><etal/>
</person-group>. (<year>1981</year>) <article-title>Saccades of hyperactive and normal boys during ocular pursuit</article-title>. <source>Dev Med Child Neurol</source> <volume>23</volume>: <fpage>323</fpage>–<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr7-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barik</surname><given-names>S</given-names></name>
<name><surname>de Beaurepaire</surname><given-names>R</given-names></name>
</person-group> (<year>1996</year>) <article-title>Evidence for a functional role of the dopamine D3 receptors in the cerebellum</article-title>. <source>Brain Res</source> <volume>737</volume>: <fpage>347</fpage>–<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr8-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bell</surname><given-names>AH</given-names></name>
<name><surname>Everling</surname><given-names>S</given-names></name>
<name><surname>Munoz</surname><given-names>DP</given-names></name>
</person-group> (<year>2000</year>) <article-title>Influence of stimulus eccentricity and direction on characteristics of pro- and antisaccades in non-human primates</article-title>. <source>J Neurophysiol</source> <volume>84</volume>: <fpage>2595</fpage>–<lpage>2604</lpage>.</citation>
</ref>
<ref id="bibr9-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ben-Pazi</surname><given-names>H</given-names></name>
<name><surname>Shalev</surname><given-names>RS</given-names></name>
<name><surname>Gross-Tsur</surname><given-names>V</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Age and medication effects on rhythmic responses in ADHD: Possible oscillatory mechanisms?</article-title> <source>Neuropsychologia</source> <volume>44</volume>: <fpage>412</fpage>–<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr10-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bidwell</surname><given-names>LC</given-names></name>
<name><surname>Dew</surname><given-names>RE</given-names></name>
<name><surname>Kollins</surname><given-names>SH</given-names></name>
</person-group> (<year>2011</year>) <article-title>Cognitive enhancers for the treatment of ADHD</article-title>. <source>Pharmacol Biochem Behav</source> <volume>99</volume>: <fpage>262</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr11-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bilder</surname><given-names>RM</given-names></name>
<name><surname>Volavka</surname><given-names>J</given-names></name>
<name><surname>Lachman</surname><given-names>HM</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes</article-title>. <source>Neuropsychopharmacology</source> <volume>29</volume>: <fpage>1943</fpage>–<lpage>1961</lpage>.</citation>
</ref>
<ref id="bibr12-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bylsma</surname><given-names>FW</given-names></name>
<name><surname>Pivik</surname><given-names>RT</given-names></name>
</person-group> (<year>1989</year>) <article-title>The effects of background illumination and stimulant medication on smooth pursuit eye movements of hyperactive children</article-title>. <source>J Abnorm Child Psychol</source> <volume>17</volume>: <fpage>73</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr13-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Camp-Bruno</surname><given-names>JA</given-names></name>
<name><surname>Herting</surname><given-names>RL</given-names></name>
</person-group> (<year>1994</year>) <article-title>Cognitive effects of milacemide and methylphenidate in healthy young adults</article-title>. <source>Psychopharmacology</source> <volume>115</volume>: <fpage>46</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr14-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carey</surname><given-names>MR</given-names></name>
<name><surname>Regehr</surname><given-names>WG</given-names></name>
</person-group> (<year>2009</year>) <article-title>Noradrenergic control of associative synaptic plasticity by selective modulation of instructive signals</article-title>. <source>Neuron</source> <volume>62</volume>: <fpage>112</fpage>–<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr15-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Castellanos</surname><given-names>FX</given-names></name>
<name><surname>Sonuga-Barke</surname><given-names>EJS</given-names></name>
<name><surname>Scheres</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability</article-title>. <source>Biol Psychiatry</source> <volume>57</volume>: <fpage>1416</fpage>–<lpage>1423</lpage>.</citation>
</ref>
<ref id="bibr16-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crawford</surname><given-names>T</given-names></name>
<name><surname>Goodrich</surname><given-names>S</given-names></name>
<name><surname>Henderson</surname><given-names>L</given-names></name><etal/>
</person-group>. (<year>1989</year>) <article-title>Predictive responses in Parkinson’s disease: Manual keypresses and saccadic eye movements to regular stimulus events</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <volume>52</volume>: <fpage>1033</fpage>–<lpage>1042</lpage>.</citation>
</ref>
<ref id="bibr17-0269881112446531">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Delaney</surname><given-names>T</given-names></name>
<name><surname>Roberts</surname><given-names>R</given-names></name>
</person-group> (<year>1999</year>) <article-title>Experimental analysis of a competitive timing model of antisaccade performance in humans</article-title>. Paper presented at the <conf-name>Meeting of the 10th European Conference on Eye Movements</conf-name>, <conf-loc>Utrecht, The Netherlands</conf-loc>, <conf-date>23–25 September 1999</conf-date>.</citation>
</ref>
<ref id="bibr18-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dépatie</surname><given-names>L</given-names></name>
<name><surname>O’Driscoll</surname><given-names>GA</given-names></name>
<name><surname>Holohan</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study</article-title>. <source>Neuropsychopharmacology</source> <volume>27</volume>: <fpage>1056</fpage>–<lpage>1070</lpage>.</citation>
</ref>
<ref id="bibr19-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ding</surname><given-names>Y-S</given-names></name>
<name><surname>Fowler</surname><given-names>JS</given-names></name>
<name><surname>Volkow</surname><given-names>ND</given-names></name><etal/>
</person-group>. (<year>1997</year>) <article-title>Chiral drugs: Comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain</article-title>. <source>Psychopharmacology</source> <volume>131</volume>: <fpage>71</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr20-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dodson</surname><given-names>WW</given-names></name>
</person-group> (<year>2005</year>) <article-title>Pharmacotherapy of adult ADHD</article-title>. <source>J Clin Psychol</source> <volume>61</volume>: <fpage>589</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr21-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Domino</surname><given-names>EF</given-names></name>
<name><surname>Ni</surname><given-names>LS</given-names></name>
<name><surname>Zhang</surname><given-names>H</given-names></name>
</person-group> (<year>1997</year>) <article-title>Effects of tobacco smoking on human ocular smooth pursuit</article-title>. <source>Clin Pharmacol Ther</source> <volume>61</volume>: <fpage>349</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr22-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elliott</surname><given-names>R</given-names></name>
<name><surname>Sahakian</surname><given-names>BJ</given-names></name>
<name><surname>Matthews</surname><given-names>K</given-names></name><etal/>
</person-group>. (<year>1997</year>) <article-title>Effects of methylphenidate on spatial working memory and planning in healthy young adults</article-title>. <source>Psychopharmacology</source> <volume>131</volume>: <fpage>196</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr23-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Engert</surname><given-names>V</given-names></name>
<name><surname>Joober</surname><given-names>R</given-names></name>
<name><surname>Meaney</surname><given-names>MJ</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Behavioral response to methylphenidate challenge: Influence of early life parental care</article-title>. <source>Dev Psychobiol</source> <volume>51</volume>: <fpage>408</fpage>–<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr24-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ettinger</surname><given-names>U</given-names></name>
<name><surname>Joober</surname><given-names>R</given-names></name>
<name><surname>De Guzman</surname><given-names>R</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Schizotypy, attention deficit hyperactivity disorder, and dopamine genes</article-title>. <source>Psychiatry Clin Neurosci</source> <volume>60</volume>: <fpage>764</fpage>–<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr25-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ettinger</surname><given-names>U</given-names></name>
<name><surname>Kumari</surname><given-names>V</given-names></name>
<name><surname>Crawford</surname><given-names>TJ</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Reliability of smooth pursuit, fixation, and saccadic eye movements</article-title>. <source>Psychophysiology</source> <volume>40</volume>: <fpage>620</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr26-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evdokimidis</surname><given-names>I</given-names></name>
<name><surname>Tsekou</surname><given-names>H</given-names></name>
<name><surname>Smyrnis</surname><given-names>N</given-names></name>
</person-group> (<year>2006</year>) <article-title>The mirror antisaccade task: Direction-amplitude interaction and spatial accuracy characteristics</article-title>. <source>Exper Brain Res</source> <volume>174</volume>: <fpage>304</fpage>–<lpage>311</lpage>.</citation>
</ref>
<ref id="bibr27-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feifel</surname><given-names>D</given-names></name>
<name><surname>Farber</surname><given-names>RH</given-names></name>
<name><surname>Clementz</surname><given-names>BA</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder</article-title>. <source>Biol Psychiatry</source> <volume>56</volume>: <fpage>333</fpage>–<lpage>339</lpage>.</citation>
</ref>
<ref id="bibr28-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gagnon</surname><given-names>D</given-names></name>
<name><surname>O’Driscoll</surname><given-names>GA</given-names></name>
<name><surname>Petrides</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>The effect of spatial and temporal information on saccades and neural activity in oculomotor structures</article-title>. <source>Brain</source> <volume>125</volume>: <fpage>123</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr29-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heal</surname><given-names>DJ</given-names></name>
<name><surname>Cheetham</surname><given-names>SC</given-names></name>
<name><surname>Smith</surname><given-names>SL</given-names></name>
</person-group> (<year>2009</year>) <article-title>The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety</article-title>. <source>Neuropharmacology</source> <volume>57</volume>: <fpage>608</fpage>–<lpage>618</lpage>.</citation>
</ref>
<ref id="bibr30-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
<name><surname>Takikawa</surname><given-names>Y</given-names></name>
<name><surname>Kawagoe</surname><given-names>R</given-names></name>
</person-group> (<year>2000</year>) <article-title>Role of the basal ganglia in the control of purposive saccadic eye movements</article-title>. <source>Physiol Rev</source> <volume>80</volume>: <fpage>953</fpage>–<lpage>978</lpage>.</citation>
</ref>
<ref id="bibr31-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
<name><surname>Wurtz</surname><given-names>RH</given-names></name>
</person-group> (<year>1983</year>) <article-title>Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses</article-title>. <source>J Neurophysiol</source> <volume>49</volume>: <fpage>1268</fpage>–<lpage>1284</lpage>.</citation>
</ref>
<ref id="bibr32-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
<name><surname>Wurtz</surname><given-names>RH</given-names></name>
</person-group> (<year>1985</year>) <article-title>Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata</article-title>. <source>J Neurophysiol</source> <volume>53</volume>: <fpage>292</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr33-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ikai</surname><given-names>Y</given-names></name>
<name><surname>Takada</surname><given-names>M</given-names></name>
<name><surname>Shinonaga</surname><given-names>Y</given-names></name><etal/>
</person-group>. (<year>1992</year>) <article-title>Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei</article-title>. <source>Neuroscience</source> <volume>51</volume>: <fpage>719</fpage>–<lpage>728</lpage>.</citation>
</ref>
<ref id="bibr34-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ilg</surname><given-names>UJ</given-names></name>
<name><surname>Thier</surname><given-names>P</given-names></name>
</person-group> (<year>2008</year>) <article-title>The neural basis of smooth pursuit eye movements in the rhesus monkey brain</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>229</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr35-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Imperato</surname><given-names>A</given-names></name>
<name><surname>Mulas</surname><given-names>A</given-names></name>
<name><surname>Di Chiara</surname><given-names>G</given-names></name>
</person-group> (<year>1986</year>) <article-title>Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats</article-title>. <source>Eur J Pharmacol</source> <volume>132</volume>: <fpage>337</fpage>–<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr36-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Isotalo</surname><given-names>E</given-names></name>
<name><surname>Pyykkö</surname><given-names>I</given-names></name>
<name><surname>Juhola</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Predictable and pseudo random saccades in patients with acoustic neuroma</article-title>. <source>Acta Otolaryngol Suppl</source> <volume>520</volume>: <fpage>22</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr37-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Itoh</surname><given-names>H</given-names></name>
<name><surname>Nakahara</surname><given-names>H</given-names></name>
<name><surname>Hikosaka</surname><given-names>O</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Correlation of primate caudate neural activity and saccade parameters in reward-oriented behavior</article-title>. <source>J Neurophysiol</source> <volume>89</volume>: <fpage>1774</fpage>–<lpage>1783</lpage>.</citation>
</ref>
<ref id="bibr38-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobsen</surname><given-names>LK</given-names></name>
<name><surname>Hong</surname><given-names>WL</given-names></name>
<name><surname>Hiommer</surname><given-names>DW</given-names></name><etal/>
</person-group>. (<year>1996</year>) <article-title>Smooth pursuit eye movements in childhood-onset schizophrenia: Comparison with attention-deficit hyperactivity disorder and normal controls</article-title>. <source>Biol Psychiatry</source> <volume>40</volume>: <fpage>1144</fpage>–<lpage>1154</lpage>.</citation>
</ref>
<ref id="bibr39-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jayaraman</surname><given-names>A</given-names></name>
<name><surname>Batton</surname><given-names>RR</given-names><suffix>3rd</suffix></name>
<name><surname>Carpenter</surname><given-names>MB</given-names></name>
</person-group> (<year>1977</year>) <article-title>Nigrotectal projections in the monkey: An autoradiographic study</article-title>. <source>Brain Res</source> <volume>135</volume>: <fpage>147</fpage>–<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr40-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname><given-names>DZ</given-names></name>
<name><surname>Fujii</surname><given-names>N</given-names></name>
<name><surname>Graybiel</surname><given-names>AM</given-names></name>
</person-group> (<year>2009</year>) <article-title>Neural representation of time in cortico-basal ganglia circuits</article-title>. <source>Proc Natl Acad Sci US</source> <volume>106</volume>: <fpage>19156</fpage>–<lpage>19161</lpage>.</citation>
</ref>
<ref id="bibr41-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>K</given-names></name>
<name><surname>Everling</surname><given-names>S</given-names></name>
</person-group> (<year>2008</year>) <article-title>Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>271</fpage>–<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr42-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Joiner</surname><given-names>WM</given-names></name>
<name><surname>Shelhamer</surname><given-names>M</given-names></name>
</person-group> (<year>2006</year>) <article-title>An internal clock generates repetitive predictive saccades</article-title>. <source>Exper Brain Res</source> <volume>175</volume>: <fpage>305</fpage>–<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr43-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kawagoe</surname><given-names>R</given-names></name>
<name><surname>Takikawa</surname><given-names>Y</given-names></name>
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
</person-group> (<year>1998</year>) <article-title>Expectation of reward modulates cognitive signals in the basal ganglia</article-title>. <source>Nature Neurosci</source> <volume>1</volume>: <fpage>411</fpage>–<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr44-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>ZU</given-names></name>
<name><surname>Gutierrez</surname><given-names>A</given-names></name>
<name><surname>Martin</surname><given-names>R</given-names></name><etal/>
</person-group>. (<year>1998</year>) <article-title>Differential regional and cellular distribution of dopamine D2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain</article-title>. <source>J Comp Neurol</source> <volume>402</volume>: <fpage>353</fpage>–<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr45-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Shin</surname><given-names>JH</given-names></name>
<name><surname>Hall</surname><given-names>FS</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Dopamine signaling is required for depolarization-induced slow current in cerebellar Purkinje cells</article-title>. <source>J Neurosci</source> <volume>29</volume>: <fpage>8530</fpage>–<lpage>8538</lpage>.</citation>
</ref>
<ref id="bibr46-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klein</surname><given-names>C</given-names><suffix>Jr</suffix></name>
<name><surname>Fischer</surname><given-names>B</given-names></name>
<name><surname>Fischer</surname><given-names>B</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>Effects of methylphenidate on saccadic responses in patients with ADHD</article-title>. <source>Exper Brain Res</source> <volume>145</volume>: <fpage>121</fpage>–<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr47-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kolasiewicz</surname><given-names>W</given-names></name>
<name><surname>Maj</surname><given-names>J</given-names></name>
<name><surname>Ossowska</surname><given-names>K</given-names></name>
</person-group> (<year>2008</year>) <article-title>The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats</article-title>. <source>J Neural Transm</source> <volume>115</volume>: <fpage>677</fpage>–<lpage>681</lpage>.</citation>
</ref>
<ref id="bibr48-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kori</surname><given-names>A</given-names></name>
<name><surname>Miyashita</surname><given-names>N</given-names></name>
<name><surname>Kato</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccades</article-title>. <source>J Neurosci</source> <volume>15</volume>: <fpage>928</fpage>–<lpage>941</lpage>.</citation>
</ref>
<ref id="bibr49-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kristjansson</surname><given-names>A</given-names></name>
<name><surname>Vandenbroucke</surname><given-names>MWG</given-names></name>
<name><surname>Driver</surname><given-names>J</given-names></name>
</person-group> (<year>2004</year>) <article-title>When pros become cons for anti- versus prosaccades: Factors with opposite or common effects on different saccade types</article-title>. <source>Exper Brain Res</source> <volume>155</volume>: <fpage>231</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr50-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurscheidt</surname><given-names>JC</given-names></name>
<name><surname>Peiler</surname><given-names>P</given-names></name>
<name><surname>Behnken</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Acute effects of methylphenidate on neuropsychological parameters in adults with ADHD: Possible relevance for therapy</article-title>. <source>J Neural Transm</source> <volume>115</volume>: <fpage>357</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr51-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lasker</surname><given-names>AG</given-names></name>
<name><surname>Isotalo</surname><given-names>EH</given-names></name>
<name><surname>Zee</surname><given-names>DS</given-names></name>
</person-group> (<year>2005</year>) <article-title>Predictive saccades to a regularly alternating target in cerebellar patients</article-title>. <source>Ann NY Acad Sci</source> <volume>1039</volume>: <fpage>544</fpage>–<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr52-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lencer</surname><given-names>R</given-names></name>
<name><surname>Trillenberg</surname><given-names>P</given-names></name>
</person-group> (<year>2008</year>) <article-title>Neurophysiology and neuroanatomy of smooth pursuit in humans</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>219</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr53-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDowell</surname><given-names>JE</given-names></name>
<name><surname>Dyckman</surname><given-names>KA</given-names></name>
<name><surname>Austin</surname><given-names>BP</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>255</fpage>–<lpage>270</lpage>.</citation>
</ref>
<ref id="bibr54-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malaspina</surname><given-names>D</given-names></name>
<name><surname>Colemann</surname><given-names>EA</given-names></name>
<name><surname>Quitkin</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>1994</year>) <article-title>Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals</article-title>. <source>Schizophr Res</source> <volume>13</volume>: <fpage>151</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr55-0269881112446531">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Marcus</surname><given-names>S</given-names></name>
<name><surname>Robins</surname><given-names>L N</given-names></name>
<name><surname>Bucholz</surname><given-names>K</given-names></name>
</person-group> (<year>1990</year>) <source>Quick Diagnostic Interview Schedule 3R Version 1</source>. <publisher-loc>St Louis, MO</publisher-loc>: <publisher-name>Washington University School of Medicine</publisher-name>.</citation>
</ref>
<ref id="bibr56-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matochik</surname><given-names>JA</given-names></name>
<name><surname>Nordahl</surname><given-names>TE</given-names></name>
<name><surname>Gross</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>1993</year>) <article-title>Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity</article-title>. <source>Neuropsychopharmacology</source> <volume>8</volume>: <fpage>377</fpage>–<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr57-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>MA</given-names></name>
<name><surname>Owen</surname><given-names>AM</given-names></name>
<name><surname>Sahakian</surname><given-names>BJ</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain</article-title>. <source>J Neurosci</source> <volume>20</volume>: <fpage>RC65</fpage>.</citation>
</ref>
<ref id="bibr58-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Melchitzky</surname><given-names>DS</given-names></name>
<name><surname>Lewis</surname><given-names>DA</given-names></name>
</person-group> (<year>2000</year>) <article-title>Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation</article-title>. <source>Neuropsychopharmacology</source> <volume>22</volume>: <fpage>466</fpage>–<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr59-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mostofsky</surname><given-names>SH</given-names></name>
<name><surname>Lasker</surname><given-names>AG</given-names></name>
<name><surname>Cutting</surname><given-names>LE</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Oculomotor abnormalities in attention deficit hyperactivity disorder: A preliminary study</article-title>. <source>Neurology</source> <volume>57</volume>: <fpage>423</fpage>–<lpage>430</lpage>.</citation>
</ref>
<ref id="bibr60-0269881112446531">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Munoz</surname><given-names>D</given-names></name>
<name><surname>Hampton</surname><given-names>K</given-names></name>
<name><surname>Moore</surname><given-names>K</given-names></name><etal/>
</person-group>. (<year>1999</year>) <article-title>Control of purposive saccadic eye movements and visual fixation in children with Attention-Deficit Hyperactivity Disorder</article-title>. In: <person-group person-group-type="editor">
<name><surname>Becker</surname><given-names>W</given-names></name>
<name><surname>Deubel</surname><given-names>H</given-names></name>
<name><surname>Mergner</surname><given-names>T</given-names></name>
</person-group> (eds). <source>Current Oculomotor Research: Physiological and Psychological Aspects</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Kluwer Academic/Plenum Publishers, pp</publisher-name>. <fpage>415</fpage>–<lpage>424</lpage>.</citation>
</ref>
<ref id="bibr61-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nagel</surname><given-names>M</given-names></name>
<name><surname>Zangemeister</surname><given-names>WH</given-names></name>
</person-group> (<year>2003</year>) <article-title>The effect of transcranial magnetic stimulation over the cerebellum on the synkinesis of coordinated eye and head movements</article-title>. <source>J Neurol Sci</source> <volume>213</volume>: <fpage>35</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr62-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>K</given-names></name>
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
</person-group> (<year>2006</year>) <article-title>Role of dopamine in the primate caudate nucleus in reward modulation of saccades</article-title>. <source>J Neurosci</source> <volume>26</volume>: <fpage>5360</fpage>–<lpage>5369</lpage>.</citation>
</ref>
<ref id="bibr63-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Driscoll</surname><given-names>GA</given-names></name>
<name><surname>Callahan</surname><given-names>BL</given-names></name>
</person-group> (<year>2008</year>) <article-title>Smooth pursuit in schizophrenia: A meta-analytic review of research since 1993</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>359</fpage>–<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr64-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Driscoll</surname><given-names>GA</given-names></name>
<name><surname>Dépatie</surname><given-names>L</given-names></name>
<name><surname>Holohan</surname><given-names>AL</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder</article-title>. <source>Biol Psychiatry</source> <volume>57</volume>: <fpage>1452</fpage>–<lpage>1460</lpage>.</citation>
</ref>
<ref id="bibr65-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Driscoll</surname><given-names>GA</given-names></name>
<name><surname>Wolff</surname><given-names>AL</given-names></name>
<name><surname>Benkelfat</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2000</year>) <article-title>Functional neuroanatomy of smooth pursuit and predictive saccades</article-title>. <source>Neuroreport</source> <volume>11</volume>: <fpage>1335</fpage>–<lpage>1340</lpage>.</citation>
</ref>
<ref id="bibr66-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Olincy</surname><given-names>A</given-names></name>
<name><surname>Ross</surname><given-names>RG</given-names></name>
<name><surname>Young</surname><given-names>DA</given-names></name><etal/>
</person-group>. (<year>1998</year>) <article-title>Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients</article-title>. <source>Neuropsychopharmacology</source> <volume>18</volume>: <fpage>175</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr67-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Sullivan</surname><given-names>EP</given-names></name>
<name><surname>Shaunak</surname><given-names>S</given-names></name>
<name><surname>Henderson</surname><given-names>L</given-names></name><etal/>
</person-group>. (<year>1997</year>) <article-title>Abnormalities of predictive saccades in Parkinson’s disease</article-title>. <source>Neuroreport</source> <volume>8</volume>: <fpage>1209</fpage>–<lpage>1213</lpage>.</citation>
</ref>
<ref id="bibr68-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pierce</surname><given-names>RC</given-names></name>
<name><surname>Kumaresan</surname><given-names>V</given-names></name>
</person-group> (<year>2006</year>) <article-title>The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?</article-title> <source>Neurosci Biobehav Rev</source> <volume>30</volume>: <fpage>215</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr69-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pietrzak</surname><given-names>RH</given-names></name>
<name><surname>Mollica</surname><given-names>CM</given-names></name>
<name><surname>Maruff</surname><given-names>P</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder</article-title>. <source>Neurosci Biobehav Rev</source> <volume>30</volume>: <fpage>1225</fpage>–<lpage>1245</lpage>.</citation>
</ref>
<ref id="bibr70-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reilly</surname><given-names>JL</given-names></name>
<name><surname>Lencer</surname><given-names>R</given-names></name>
<name><surname>Bishop</surname><given-names>JR</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Pharmacological treatment effects on eye movement control</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>415</fpage>–<lpage>435</lpage>.</citation>
</ref>
<ref id="bibr71-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Repantis</surname><given-names>D</given-names></name>
<name><surname>Schlattmann</surname><given-names>P</given-names></name>
<name><surname>Laisney</surname><given-names>O</given-names></name><etal/>
</person-group>. (<year>2010</year>) <article-title>Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review</article-title>. <source>Pharmacol Res</source> <volume>62</volume>: <fpage>187</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr72-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rommelse</surname><given-names>NNJ</given-names></name>
<name><surname>Van der Stigchel</surname><given-names>S</given-names></name>
<name><surname>Sergeant</surname><given-names>JA</given-names></name>
</person-group> (<year>2008</year>) <article-title>A review on eye movement studies in childhood and adolescent psychiatry</article-title>. <source>Brain Cogn</source> <volume>68</volume>: <fpage>391</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr73-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubia</surname><given-names>K</given-names></name>
<name><surname>Noorloos</surname><given-names>J</given-names></name>
<name><surname>Smith</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Motor timing deficits in community and clinical boys with hyperactive behavior: The effect of methylphenidate on motor timing</article-title>. <source>J Abnorm Child Psychol</source> <volume>31</volume>: <fpage>301</fpage>–<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr74-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sailer</surname><given-names>U</given-names></name>
<name><surname>Eggert</surname><given-names>T</given-names></name>
<name><surname>Straube</surname><given-names>A</given-names></name>
</person-group> (<year>2005</year>) <article-title>Impaired temporal prediction and eye-hand coordination in patients with cerebellar lesions</article-title>. <source>Behav Brain Res</source> <volume>160</volume>: <fpage>72</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr75-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schweighofer</surname><given-names>N</given-names></name>
<name><surname>Doya</surname><given-names>K</given-names></name>
<name><surname>Kuroda</surname><given-names>S</given-names></name>
</person-group> (<year>2004</year>) <article-title>Cerebellar aminergic neuromodulation: Towards a functional understanding</article-title>. <source>Brain Res Brain Res Rev</source> <volume>44</volume>: <fpage>103</fpage>–<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr76-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schweitzer</surname><given-names>JB</given-names></name>
<name><surname>Lee</surname><given-names>DO</given-names></name>
<name><surname>Hanford</surname><given-names>RB</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>A positron emission tomography study of methylphenidate in adults with ADHD: Alterations in resting blood flow and predicting treatment response</article-title>. <source>Neuropsychopharmacology</source> <volume>28</volume>: <fpage>967</fpage>–<lpage>973</lpage>.</citation>
</ref>
<ref id="bibr77-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seamans</surname><given-names>JK</given-names></name>
<name><surname>Yang</surname><given-names>CR</given-names></name>
</person-group> (<year>2004</year>) <article-title>The principal features and mechanisms of dopamine modulation in the prefrontal cortex</article-title>. <source>Progr Neurobiol</source> <volume>74</volume>: <fpage>1</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr78-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sherr</surname><given-names>JD</given-names></name>
<name><surname>Myers</surname><given-names>C</given-names></name>
<name><surname>Avila</surname><given-names>MT</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>The effects of nicotine on specific eye tracking measures in schizophrenia</article-title>. <source>Biol Psychiatry</source> <volume>52</volume>: <fpage>721</fpage>–<lpage>728</lpage>.</citation>
</ref>
<ref id="bibr79-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simó</surname><given-names>LS</given-names></name>
<name><surname>Krisky</surname><given-names>CM</given-names></name>
<name><surname>Sweeney</surname><given-names>JA</given-names></name>
</person-group> (<year>2005</year>) <article-title>Functional neuroanatomy of anticipatory behavior: Dissociation between sensory-driven and memory-driven systems</article-title>. <source>Cereb Cortex</source> <volume>15</volume>: <fpage>1982</fpage>–<lpage>1991</lpage>.</citation>
</ref>
<ref id="bibr80-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simon</surname><given-names>H</given-names></name>
<name><surname>Le Moal</surname><given-names>M</given-names></name>
<name><surname>Calas</surname><given-names>A</given-names></name>
</person-group> (<year>1979</year>) <article-title>Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase</article-title>. <source>Brain Res</source> <volume>178</volume>: <fpage>17</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr81-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smyrnis</surname><given-names>N</given-names></name>
<name><surname>Evdokimidis</surname><given-names>I</given-names></name>
<name><surname>Stefanis</surname><given-names>NC</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>The antisaccade task in a sample of 2,006 young males. II. Effects of task parameters</article-title>. <source>Exper Brain Res</source> <volume>147</volume>: <fpage>53</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr82-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Straube</surname><given-names>A</given-names></name>
<name><surname>Riedel</surname><given-names>M</given-names></name>
<name><surname>Eggert</surname><given-names>T</given-names></name><etal/>
</person-group>. (<year>1999</year>) <article-title>Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part I. Saccadic velocity</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source> <volume>249</volume>: <fpage>1</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr83-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swanson</surname><given-names>J</given-names></name>
<name><surname>Baler</surname><given-names>RD</given-names></name>
<name><surname>Volkow</surname><given-names>ND</given-names></name>
</person-group> (<year>2011</year>) <article-title>Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: A decade of progress</article-title>. <source>Neuropsychopharmacology</source> <volume>36</volume>: <fpage>207</fpage>–<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr84-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sweeney</surname><given-names>JA</given-names></name>
<name><surname>Clementz</surname><given-names>BA</given-names></name>
<name><surname>Haas</surname><given-names>GL</given-names></name><etal/>
</person-group>. (<year>1994</year>) <article-title>Eye tracking dysfunction in schizophrenia: Characterization of component eye movement abnormalities, diagnostic specificity, and the role of attention</article-title>. <source>J Abnorm Psychol</source> <volume>103</volume>: <fpage>222</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr85-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takikawa</surname><given-names>Y</given-names></name>
<name><surname>Kawagoe</surname><given-names>R</given-names></name>
<name><surname>Itoh</surname><given-names>H</given-names></name><etal/>
</person-group>. (<year>2002</year>) <article-title>Modulation of saccadic eye movements by predicted reward outcome</article-title>. <source>Exper Brain Res</source> <volume>142</volume>: <fpage>284</fpage>–<lpage>291</lpage>.</citation>
</ref>
<ref id="bibr86-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tedeschi</surname><given-names>G</given-names></name>
<name><surname>Bittencourt</surname><given-names>PR</given-names></name>
<name><surname>Smith</surname><given-names>AT</given-names></name><etal/>
</person-group>. (<year>1983</year>) <article-title>Effect of amphetamine on saccadic and smooth pursuit eye movements</article-title>. <source>Psychopharmacology</source> <volume>79</volume>: <fpage>190</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr87-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Udo</surname><given-names>de</given-names></name>
<name><surname>Haes</surname><given-names>JI</given-names></name>
<name><surname>Maguire</surname><given-names>RP</given-names></name>
<name><surname>Jager</surname><given-names>PL</given-names></name><etal/>
</person-group>. (<year>2007</year>) <article-title>Methylphenidate-induced activation of the anterior cingulate but not the striatum: A [15O]H2O PET study in healthy volunteers</article-title>. <source>Hum Brain Mapp</source> <volume>28</volume>: <fpage>625</fpage>–<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr88-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ventre</surname><given-names>J</given-names></name>
<name><surname>Zee</surname><given-names>DS</given-names></name>
<name><surname>Papageorgiou</surname><given-names>H</given-names></name><etal/>
</person-group>. (<year>1992</year>) <article-title>Abnormalities of predictive saccades in hemi-Parkinson’s disease</article-title>. <source>Brain</source> <volume>115</volume>: <fpage>1147</fpage>–<lpage>1165</lpage>.</citation>
</ref>
<ref id="bibr89-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volkow</surname><given-names>ND</given-names></name>
<name><surname>Ding</surname><given-names>Y-S</given-names></name>
<name><surname>Fowler</surname><given-names>JS</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain</article-title>. <source>Arch Gen Psychiatry</source> <volume>52</volume>: <fpage>456</fpage>–<lpage>463</lpage>.</citation>
</ref>
<ref id="bibr90-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volkow</surname><given-names>ND</given-names></name>
<name><surname>Wang</surname><given-names>GJ</given-names></name>
<name><surname>Fowler</surname><given-names>JS</given-names></name><etal/>
</person-group>. (<year>1997</year>) <article-title>Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors</article-title>. <source>Am J Psychiatry</source> <volume>154</volume>: <fpage>50</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr91-0269881112446531">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Volkow</surname><given-names>ND</given-names></name>
<name><surname>Wang</surname><given-names>G</given-names></name>
<name><surname>Fowler</surname><given-names>JS</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain</article-title>. <source>J Neurosci</source> <volume>21</volume>: <publisher-name>RC121</publisher-name>.</citation>
</ref>
<ref id="bibr92-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volkow</surname><given-names>ND</given-names></name>
<name><surname>Wang</surname><given-names>GJ</given-names></name>
<name><surname>Fowler</surname><given-names>JS</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain</article-title>. <source>Am J Psychiatry</source> <volume>161</volume>: <fpage>1173</fpage>–<lpage>1180</lpage>.</citation>
</ref>
<ref id="bibr93-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>K</given-names></name>
<name><surname>Lauwereyns</surname><given-names>J</given-names></name>
<name><surname>Hikosaka</surname><given-names>O</given-names></name>
</person-group> (<year>2003</year>) <article-title>Neural correlates of rewarded and unrewarded eye movements in the primate caudate nucleus</article-title>. <source>J Neurosci</source> <volume>23</volume>: <fpage>10052</fpage>–<lpage>10057</lpage>.</citation>
</ref>
<ref id="bibr94-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>M</given-names></name>
<name><surname>Munoz</surname><given-names>DP</given-names></name>
</person-group> (<year>2009</year>) <article-title>Neural correlates of conflict resolution between automatic and volitional actions by basal ganglia</article-title>. <source>Eur J Neurosci</source> <volume>30</volume>: <fpage>2165</fpage>–<lpage>2176</lpage>.</citation>
</ref>
<ref id="bibr95-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wiener</surname><given-names>M</given-names></name>
<name><surname>Turkeltaub</surname><given-names>P</given-names></name>
<name><surname>Coslett</surname><given-names>HB</given-names></name>
</person-group> (<year>2010</year>) <article-title>The image of time: A voxel-wise meta-analysis</article-title>. <source>Neuroimage</source> <volume>49</volume>: <fpage>1728</fpage>–<lpage>1740</lpage>.</citation>
</ref>
<ref id="bibr96-0269881112446531">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilens</surname><given-names>TE</given-names></name>
<name><surname>Adler</surname><given-names>LA</given-names></name>
<name><surname>Adams</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Misuse and diversion of stimulants prescribed for ADHD</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source> <volume>47</volume>: <fpage>21</fpage>–<lpage>31</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>